Literature DB >> 29276456

Visual and anatomic outcomes of vitreoretinal surgery: results at the Boston VA and a review of the literature.

Nicole C Hanley-Williams1, Manju L Subramanian1,2, Edward B Feinberg1,2.   

Abstract

INTRODUCTION: The veteran population presents unique challenges in the management of vitreoretinal disorders. We compiled the surgical outcomes for the most common visually significant vitreoretinal diagnoses. Those results were then compared to visual and anatomic outcomes established in the literature.
MATERIALS AND METHODS: Medical records over a three-year time period, from January 2005 through December 2007, were reviewed for 208 persons who underwent vitreoretinal surgery for vitreous hemorrhage, retained lens fragment, rhegmatogenous and tractional retinal detachment, macular hole, and macular pucker at the Jamaica Plain Campus of the Veterans Affairs Boston Healthcare System in Boston, MA. A comprehensive search of the literature was conducted on Medline. Data from several large case series and meta-analyses were compared to results obtained at the VA Boston.
RESULTS: A total of 208 veterans underwent vitreoretinal surgery from January 2005 to December 2007. After excluding those with rare diagnoses and lack of adequate follow-up data, the outcomes of 181 vitreoretinal procedures were included in this study. DISCUSSION: Overall, veterans at a regional referral center in Boston demonstrate postoperative visual and anatomic outcomes comparable to outcomes reported in the ophthalmic literature.

Entities:  

Year:  2009        PMID: 29276456      PMCID: PMC5735599          DOI: 10.5693/djo.01.2009.005

Source DB:  PubMed          Journal:  Digit J Ophthalmol        ISSN: 1542-8958


  41 in total

1.  The macular hole: report of an Australian surgical series and meta-analysis of the literature.

Authors:  H K Kang; A A Chang; P E Beaumont
Journal:  Clin Exp Ophthalmol       Date:  2000-08       Impact factor: 4.207

2.  Clinical features and outcomes of pars plana vitrectomy in patients with retained lens fragments.

Authors:  Ingrid U Scott; Harry W Flynn; William E Smiddy; Timothy G Murray; Jeffrey K Moore; Dagmar R Lemus; William J Feuer
Journal:  Ophthalmology       Date:  2003-08       Impact factor: 12.079

Review 3.  An evidence-based analysis of surgical interventions for uncomplicated rhegmatogenous retinal detachment.

Authors:  Seang-Mei Saw; Gus Gazzard; Ajeet M Wagle; Jimmy Lim; Kah-Guan Au Eong
Journal:  Acta Ophthalmol Scand       Date:  2006-10

4.  Surgical management of macular holes: a report by the American Academy of Ophthalmology.

Authors:  W E Benson; K C Cruickshanks; D S Fong; G A Williams; M A Bloome; D A Frambach; A E Kreiger; R P Murphy
Journal:  Ophthalmology       Date:  2001-07       Impact factor: 12.079

5.  Proper method for calculating average visual acuity.

Authors:  J T Holladay
Journal:  J Refract Surg       Date:  1997 Jul-Aug       Impact factor: 3.573

6.  The prevalence of diabetic retinopathy among adults in the United States.

Authors:  John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman
Journal:  Arch Ophthalmol       Date:  2004-04

7.  Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery.

Authors:  Wendy Tseng; Rafael T Cortez; Gema Ramirez; Sandra Stinnett; Glenn J Jaffe
Journal:  Am J Ophthalmol       Date:  2004-06       Impact factor: 5.258

8.  Acute macular pucker.

Authors:  Richard M Sheard; Charanjit Sethi; Zdenek Gregor
Journal:  Ophthalmology       Date:  2003-06       Impact factor: 12.079

9.  Functional and anatomic outcome of retinal detachment surgery in pseudophakic eyes.

Authors:  Päivi Ranta; Tero Kivelä
Journal:  Ophthalmology       Date:  2002-08       Impact factor: 12.079

10.  Retinal detachment after cataract surgery: retrospective study of 57 cases.

Authors:  E Frau; H Sam; J F Korobelnik; D Chauvaud
Journal:  Eur J Ophthalmol       Date:  1993 Oct-Dec       Impact factor: 1.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.